This review summarizes the potential role of gut microbes and their metabolites as novel
mediators of psoriasis, including their composition and function in disease pathogenesis …

Background Cutaneous T‐cell lymphoma (CTCL) patients often suffer from recurrent skin
infections and profound immune dysregulation in advanced disease. The gut microbiome …

Background Psoriasis is a chronic autoinflammatory skin disease, and its aetiology remains
incompletely understood. Recently, gut microbial dysbiosis is found to be tightly associated …

The bacterial microbiota in the skin and intestine of patients with psoriasis were different
compared with that of healthy individuals. However, the presence of a distinct blood …

Scope Continuous ultraviolet (UV) exposure causes skin photoaging, wrinkle formation, and
skin barrier damage. In this study, the protective effect of mixed probiotics (MP) against …

Previous studies have profiled the gut microbiota among psoriatic patients compared to that
among healthy individuals. However, a comprehensive understanding of the magnitude …

To investigate the effect and mechanism of polydatin on bleomycin (BLM)‐induced
pulmonary fibrosis in a mouse model. The lung fibrosis model was induced by BLM. The …

Psoriasis is a chronic, systemic, immune-mediated, inflammatory skin disease associated
with significant comorbidities. Globally, there are an estimated 60 million people living with …

Advances in technology have led to an increased number of studies investigating the
microbiome in patients with psoriasis. This systematic review examined data regarding the …

There is growing evidence that supports a role of gut dysbiosis in the pathogenesis of
psoriasis (Pso). Thus, probiotic supplementation and fecal microbiota transplantation may …